Text extracted via OCR from the original document. May contain errors from the scanning process.
ti,901.000
1. 8V1
tel: (212) 879-0800 fax: (212) 988-1634
6 re
I 11
TO:
Z-e--f-C`Pt
e
FAX #:
TEL #:
Regarding:
Number of pages (including cover
Remarks:
page):
4£9L886ZLZL LPsu
H kuLE SO 9 LOZ 60 abed
EFTA01733939
bity/ I, • tlr,
• ...YON. , ••••••••,..Yinavill trollwit
Max +NW br,rne trim Mar Noel tempi' v.' AO t!,
Miramar. L ism m.,:a.W.2.ttiat,rat. irrar:
M.Priabt
IDat ammardar irararammilimatoraniaramitetri iraris
2.0arar bar L Hit II 44, O
i
irri
d
to tar limbrutrOwnIkbh
I/Its banns, tow ,~
3110PM,I1,60
,
etmbecw. Opplanit VW)
801.12.0.70
•
EFTA01733940
kg 09 2016 0937FII Harry Hach 12129861634
e
teetireni A
.,
L'422
r
e-Y-nernA"
EFTA_R1_00010816
EFTA01733941
L490L000- fti- V133
FINAL REPORT
MANJA.IMWAII"\WAAAI'ml
- EPSTEIN,
) D08:01/29/1953
Address:3 w NEW YORK,
P:
(212)
,
LABORATORIES
n
FISCH, HARRY
0
944 PARK AVENUE
New York, NY 10028
Acct I:
(C1720-1)
Si
0 P: (212) 879-0800
P,
JEFFREY
Age:63 Y Sex:/1
E 71ST STREET
NY 10021
772-9415
S Specimen ID: 105819158
A
Date Of Report: 07/23/2016
M
Date Collected: 07/20/2016
Time Collected: 08:52
i)
Date Received: 07/20/2016
L
Time Received: 23:20
C
North America Eastern Time
C_INICA'_ REPOt:
Clinical Abnormalities Suarnary: ;may ra :ortaw ae aoname [ewes. eau ve toots may rot babe aonnat laps muse 'mew tome report)
Creatinine
0.62 LO
BUN/Creat Ratio
Cholesterol
210 HI
Triglycerides
HDL as % of
13
Chol/HDL Ratio
Cholesterol
MDC
35.2 HI
Hemoglobin A1c
5.9 HI
33.9 HI
ALT
42 HI
950 HI
HDL CHOL., DIRECT 28 LO
7.5
NON FASTING
CHEMISTRY
-t"'
-
.syk'ilitirga,:a.hiata,..
?,*-V,TirL:T.1-,AAK::£11;02.9);,:n).::::::2447.1AOM4.,
total Protein
7.0
5.9-8.4 g/dL
6.7
.01/27/2016 ,Albumin
4.7
3.5.5.2 g/dL
4.2
01/27/2916
Globulin
2.3
1.7-3.7 g/dL
2.5
01/27/2016
A/G Ratio
2.0
1.1-2.9
1.7
01/27/2016
Glucose
93
70-99 mg/dL
99
01/27/2016
Sodium
140
135-147 msol/L
141
01/27/2016 rE /W
Potassium
4.6
3.5-5.5 esol/L
4.2
Chloride
97
96-188 mmol/L
102
01/27/2016
CO2
24
22-29 msol/L
26
01/27/2016
BUN
21
8-23 mg/dL
22
01/27/2016
Creatinine
0.62 LO
6.89-1.30 mg/dL
1.11
81/27/2016 e-GFR
106
>orm68 mi/min
70
01/27/2816 e-GFR, African American
123 x)rm60 et/min
81
01/27/2016
BUN/Crest Ratio
33.9 HI
10.9-28.0
19.8
01/27/2016
Calcium
9.8
8.6.18.4 mg/dL
9.8
01/27/2016
Uric Acid
7.4
3.4-8.5 mg/dL
7.5
81/27/2016
Iron
96
45-160 ug/dL
75
01/27/2016
Bilirubin, Total
0.6
<1.2 mg/dL
0.5
81/27/2816
LD
286
135-225
U/L
171
01/27/2016
Alk Phas
70
40-156
U/L
43
01/27/2016
AST
32
<40
U/L
29
01/27/2016
Phosphorus
3.8
2.7.4.5 mg/dL
3.4
01/27/2016
ALT
42 HI
<41
U/L
29
01/27/2016
GGTP
19
C:4RDT0',./SClili,R
TPT0c-
,
Cholestero
220 HI
10-71
U/L
:
<200
•L
18
„.
143
81/27/2016
(
01/27/2016
Triglycerides
958 HI
ROTE: The result for Triglycerides has been confirmed
<150 mg/di
459 HI by repeat analysis.
01/27/2016
28 LO
>40 mg/dL
24 LO
HDL as % of Cholesterol
13
Evaluation: MOVE AVG.(HODERATE RISK)
101/27/2016
>14
X
!
17
01/27/2016
Chol/HDL Ratio
7.5
<7.4
6.0
81/27/2016
BioReference Laboratories, Inc.
481 tdward H. Ross Dr I Elmwood Park, N2 07407 I (800) 219-5227
lames Heisberger, N.D.
Clinical Page 1 of 6
Laboratory Director
Printed 07/25/2016 07:01 a6ed
4£91926ZI.a. L-Pstd kueH WdL£SO 9I.62 60 5rY
EFTA01733942
9490L000
L2!—V.Ld3
FINAL REPORT
J-11,01NA,w1kwl1/44.1%.As e ''W
LABORATORIES
•
I
', EPSTEIN,
•
.3
D08:01/20/1953
Address:9
NEW YORK,
P:
(212)
t
...e
Ti
—s.t.
JEFFREY
Age:63 Y Sex:M
E 71ST STREET
NY 10021
772-9416
RISCH, HARRY
,
C
944 PARK AVENUE
New York, NV 10028
T
Acct *:
(C1720-1)
SI
P: (212) 879-0800
.
s
Specimen ID: 105819158
A
Date Of Report: 87/23/2016
M
Date Collected: 07/20/2016
Time Collected: 08:52
P
Date Received: 07/20/2016
l
Time Received: 23:20
E
North America Eastern Time
CLINICAL REPORT
$
a .1 ...40
.,
Evaluation: ABOVE AVG.(MODERATE RISK)
$4: :1004440072‘111dIR - IWO ' ,r ,iir
LDL/HDL Rat10
Can't Calc
<3.56
I
Can't Calc
01/27/2016
LDL Cholesterol
Can't Calc
NOTE: Unable to calculate LOL due to a Triglyceride .evel
<100 mg/dl.
of greater than 400 mg/dL.
Can't Calc
01/27/2016
Can't Calc
7-32 mg/dL
Can't Calc
01/27/2016
Can't Calc: One or more components was outside the measurable
range. We are unable to calculate.
HENA1OLOGY
Wit'-t--; :!;-?:;It•;.:•14:
•
'
- ,,,:14.4(4n _.
4., ' ...,:it..t. :,142:',:: -31.:.; •
•
•
....3LX:S1,„Z
WBC
7.79
3.66-11.99 x10(3)/uL
7.12
01/27/2816
RBC
5.18
4.20-5.90 x10(5)/ut
4.96
01/27/2016
HGO
15.4
12.3-17.0 gm/di.
14.3
01/27/2016
HCT
43.8
39.3-52.5
%
41.3
01/27/2016
MCV
84.6
80.0-100.0 fL
83.3
01/27/2016
MCH
29.7
25.0-34.1
pg
28.8
01/27/2016
MCHC
35.2 HI
29.0-35.0 gm/dL
34.6
01/27/2016
ROW
14.8
10.9-16.9
%
13.9
01/27/2016
POLYS
45.8
36.0-78.0
%
49.2
01/27/2016
LYMPH5
39.0
12.0-48.0
%
36.2
01/27/2016
MON05
8.9
0.0-13.0
%
7.6
01/27/2016
E05
5.4
0.0-8.0
X
6.5
02/27/2016
BASOS
0.6
0.0-2.0
X
0.4
01/27/2016
0.0
0.0-1.6
%
0.1
91/27/2016
PLATELET COUNT
281
144-400 x10(3)/uL
222
01/27/2016
MPV
8.9
NOTE: New reference ranges for WBC and Absolute coun.s
8.2-11.9
fL
9.5 are effective 4/2S/2016.
01/27/2016
PT
Ttf?
Test Not Performed: Specimen REJECTED for testing due
9.1-11.9
to GROSS LIPEMIA.
sec
10.1
01/27/2016
TNP
2.00-3.00 sec
0.97 10
01/27/2016
PTT
TNP
23.6-31.6
26.5
01/27/2016
URINIILYSIS itiglaShiiiiS,azo.L.:-. ,:ilktittabittLT1;$'4' '
Color
YELLOW
YELLOW,
STRAW, AMBER
Character
CLEAR
CLEAR
Specific Gravity Ur
1.025
1.003 -
1.030 pH Urine
6.5
5.0 - 8.0
Protein, Urine
NEGATIVE
NEGATIVE
Glucose, Urine
NEGATIVE
NEGATIVE
Ketone, Urine
NEGATIVE
NEGATIVE
Urobilinogen Urine
0.2
0.2 - 1.0 mg/dL sioReference Laboratories, Inc.
481 Edward H. Ross Dr I Elmwood Park, N3 07407 I (800) 2:
lames Weisberger, M.D.
Clinical Page 2 of 6
9-5227
Laboratory Director
Printed 07/25/2016 07:01 g abed
4£9L886ZLZ1 LIDsH /URN Wd8£:50 9L02 60 6rr
EFTA01733943
6480 L000L8Thild3
Dieference
LABORATORIES
O
gISCH, HARRY
c
C
944 PARK AVENUE
New York, NY 10028
Acct It:
(C1720-1)
51
0
P: (212) 879-0800
P.
EPSTEIN,
DOB:01/20/1953
Address:,
yy
e
NEW YORK,
P:
(212)
.'
.4
4
JEFFREY
Age:63 Y5ex:M
E 71ST STREET
NY 10021
772-9416
c
Specimen ID: 105819158
A
Date Of Report: 07/23/2816
‘.1
Date Collected: 07/20/2016
Time Collected: 08:52
P
Date Received: 07/20/2016
'
Time Received: 23:20
E
North America Eastern Time
Cr_INIC:4•1 REPORT
....Thi ilitZYA•fgOic.i4;:nt
Bilirubin, Urine
NEGATIVE
•
NEGATIVE
eu
Blood, Urine
NEGATIVE
NEGATIVE
Nitrites Urine
NEGATIVE
NEGATIVE
Leukocyte Esterase
NEGATIVE
NEGATIVE
Crystals Urine
NONE
NONE
Crystal Amt. Urine
NONE
NONE
WBC, Urine
0-4
0-4
PER HPF
RBC, Urine
NONE SEEN
NONE SEEN
PER HPF
Epithelial Cells, Ur
NONE
FEW
Cast, Hyaline, Urine
0-4
0-4
PER LPF
Cast, Granular, Ur
NONE SEEN
0-1
PER LPF
Cast, RBC, Urine
NONE SEEN
0-1
PER LPF
Bacteria, Urine
NONE
FEW
VITCRORTOECCN kigit...,t;ai;V.44-4:„.„1
.
y
CULTURE, URINE
NO GROWTH
SITE: URINE nisciLLPNLcus ,+.?..,*,24:Tifd4W1816.4,L,-,. .
NO GROWTH
.-
:.."*.'xr —" C ,:' 7.-'," ir/' --"
Hemoglobin Alc
5.9 HI
HEMOGLOBIN A1c AND eAG REFERENCE RANGES
Alc(%)
DIABETES CATEGORY*
<5.7
Normal (nos
5.7-6.4
Increased risk
.>6.5
Consistent
Aic(%) eAG(ESTimATED AVERAGE
6
126
7
154
8
103
9
212
10
240
11
269
12
298
'recommended ranges-American Diabetes
NOTE: Hemalysis, rare hemoglobin variants and thalavemia
<5.7
6.0 HI
101/27/2016
-diabetic) of diabetes with diabetes
PLASMA GLUCCGE)(mg/dL)
Association(2010) major may affect glycemic results.
TSH
TNP
Test Not Performed: Specimen rejected for testing due hemolysis.
0.178-4.530 uIU/ml.
i
1.790
101/27/2016
to moderate or marked
Thyroxine(T4)
TNP
Test Not Performed: Specimen rejected for testing due
4.9-12.9 ug/dL
to moderate or marked
6.3
101/27/2016
FINAL REPORT
BioReference Laboratories, Inc.
481 Edward N. Ross Dr I Elmwood Park, N3 07407 I (800) 2 lames Weisberger, A.D.
Clinical Page 3 of 6
-5227
Laboratory Director
Printed 87/25/2016 07:01 g abed
4£9L886ZLZL LPsY AlleH Wd6E:g0 9LOZ 60 6w
EFTA01733944
OSSOL000 1.8Thild3
BioReference
LABORATORIES
OIscm, HARRY
944 PARK AVENUE
New York, NY 10028
Acct It:
(C1720-1)
Si
P: (212) 879-0800 herolysis.
EPSTEIN, 3EFFREY
D08:01/20/1953 Age:63 V Sex:M
Address:9 E 71ST STREET
NEW YORK NY 10021
P:
(212) 772-9416
T3 Uptake(T3U)
TNP
24.3-39.0
%
Test Not Performed: Specimen rejected for testing due to moderate or marked
hemolysis.
FINAL REPORT
S
A
td
L
F
Specimen ID: 105819158
Date Of Report: 07/23/2016
Date Collected: 07/20/2016
Time Collected: 08:52
Date Received: 07/20/2016
Time Received: 23:20
North America Eastern Time
29.3
101/27/2016
THYROXINE, FREE(FT4)
TNP
0.80-1.73 ng/dL
Test Not Performed: Specimen rejected for testing dut to moderate or marked
heaolysis.
FREE T4 INDEX
TNP
1.5-3.8
T3(THYRONINE), TOTAL
TNP
72-180 ng/dL
Test Not Performed: Specimen rejected for testing due to moderate or marked
hemolysis.
PSA Total
TNP
<4.00 ng/ml.
Test Not Performed: Specimen rejected for testing due to moderate or marked
hemolysis.
101/27/2016
1.8
101/27/2016
127
01/27/2016
NOTE: The PSA assay should not be the only test used for diagnostic purposes.
Additional evaluation using ORE, ultrasound, TUR or similar procedures may
be used for this purpose. Predictions of disea e recurrence should not be
based solely upon values obtained from serial PSA values obtained on the
patient.
NOTE: Values obtained with different assay methods or kits cannot be
used interchangeably.
NOTE: Results cannot be interpreted as absolute evidence of the presence or
absence of malignant disease.
ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics)
PSA, FREE
TNP
Not Estab.
ng/mL
Test Not Performed: Specimen rejected for testing due to moderate or marked
hemolysis.
0.70
101/27/2016
NOTE: Results cannot be interpreted as absolute evidence of the
presence or absence of malignant disease. values obtained with different assay methods or kits cannot be used
interchangeably.
ASSAY INFORMATION: Method ElectrochemilumineSCence IamunOaSSay
(Roche Diagnostics).
% FREE PSA
TNP
0.33
T01/27/2016
See Below
%
The probability of prostate cancer for men with non-suspicious DRE results, by
age group, using PSA values between 4.000 and 10.080 ng/mL and percent FREE PSA
values is sumarized in the table below:
BioReference Laboratories, Inc.
lames Weisberger, N.D.
481 Edward H. Ross Dr I Elmwood Park, NI 07407 I (800) 2:9-5227
Laboratory Director
47
161/27/2016
Clinical Page 4 of 6
Printed 07/25/2016 07:01
L abed
4E9LS86ZLZI WSJ £ueH kHOP:SO 9142 60 6ny
EFTA01733945
LS801.000laVid3
BioReference
?...-4cSZSI.er
LABORATORIES
.iEPSTE/N,
9
'1000:01/20/1953
4address:1
NEW YORK
P:
(21t
—ji
JEFFREY
Ago:63 YSOX:M
E 71ST STREET
NY 10021
) 772-9416
FINAL KEPOKI
6
•
FISCH, HARRY
944 PARK AVENUE
New York, NY 10028
Acct 0:
(C1720-1)
Si
P: (212) 879-0800
5 Specimen ID: 105819158
4
Date Of Report: 07/23/2016
Date Collected: 07/20/2016
Time Collected: 08:52
P
Date Received: 07/20/2016
I
Time Received: 23:20
F
T
North America Eastern Time
CLINICAL REPORT
OF CANCER.
PROSABILIIY
%free PSA
(50-59 yrs) (60-69 yrs)
(>orp yrs) cor.10
49.2%
57.5%
64.5%
11-18
26.9%
33.9%
40.8%
19-25
18.3%
23.9%
29.7%
>25
9.1%
12.2%
15.8%
'probability of finding prostate cancer by need e biopsy
NOTE: Calculation of percent FREE PSA may not be pos ible when the value for
TOTAL PSA is in the low mammal range. These gu delines are for assays
performed using the Roche E602 immunoassay syS em.(8/2015;V8.0)
TNP
193.0-740.0 ng/dL
296.0
101/27/2016
Test Not Performed: Specimen rejected for testing due hemolysis.
to moderate or marked
TNP
72.0-460.0 ng/dL
183.8
01/27/2016
TNP
10-57 nmol/L
18
01/27/2016
Test Not Performed: Specimen rejected for testing due hemolysis.
to moderate or marked
TNP
30.00-150.00 pg/mt
80.18
101/27/2016
LH
TNP
1.7-8.6 mIll/ml
6.8
01/27/2016
Test Not Performed: Specimen rejected for testing due hemolysis.
to moderate or marked
FSH
TNP
1.5-12.4 mIU/mt
fl
6.8
01/27/2016
Test Not Performed: Specimen rejected for testing due hemolysis.
to moderate or marked
TNP
4.0-15.2 ng/mL
3.0 LO
101/27/2016 lest Not Performed: Specimen rejected for testing due
hemolysis.
to moderate or marked
ESTRADIOL
INF,
7.02-49.06 pg/ml
48.93
01/27/2016
Test Not Performed: Specimen rejected for testing due hemolysis.
to moderate or marked
FIBRINOGEN
TNP
176-441 mg/a
276
DIHYDROTESTOSTERONS(7)
146.0
106-719 pg/m1
278.0
101/27/2016
01/27/2016
Reference Intervals for Males age 20 years and above:
106.0-719.0 pg/mL
Analysis by High Performance Liquid Chromatography/
TandemMass Spectrometry (LC-MS/MS)
(7)
Performed by: National Medical Lab
2300 Stratford Ave.
Willow Grove, PA 19090 eioeeference Laboratories, Inc.
481 Edward H. Ross Dr I Elmwood Park, Nl 07467 I (800)
Jones Weisberger, M.D.
Clinical Page 5 of 6
-5227
Laboratory Director
Printed 07/25/2016 07:01
8 abed
VE9L886ZLZL ku8H l'HOVS0 9LOZ 60 find
EFTA01733946